On September 25, 2025, the FDA approved a type of leucovorin drug after President Donald Trump and U.S. Health Secretary RJK Jr. announced its potential as an “autism therapy”. (Julia Ma)
This piece was originally published in Zephyrus’ print edition on Nov. 6, 2025
Multitalented second-year staff artist. D1 crashout, procrastinator, and hater. Spiderman and Billie Eilish enthusiast. Competitive yapper. Chronically sleep-deprived. Please donate to the poor (me).
Comments (0)
Zephyrus welcomes and encourages our readers to engage in our content through substantive, respectful exchanges. To ensure our comments meet these standards, Zephyrus reviews all comments before publication and does not allow comments which contain profanity, vulgarity, racial slurs, or personal attacks. Any comments that violate these standards will be removed.